A Look At Marqeta (MQ) Valuation After European Expansion And Software Sector Pullback

Marqeta (MQ) is back in focus after two contrasting developments: an expansion of its account and money movement tools into 30 additional European countries, and a sharp 7.6% pullback in the stock.

See our latest analysis for Marqeta.

The recent 7.6% daily drop fits into a wider pattern of weak momentum, with the share price down 10.8% over the past week and 16.4% year to date, and the 1 year total shareholder return falling 28.3% despite product expansion headlines and sector wide swings.

If this payments pullback has you looking beyond a single stock, it could be a good time to broaden your search with 62 profitable AI stocks that aren't just burning cash

With Marqeta’s stock under pressure despite European expansion, you have to ask whether today’s US$3.88 price reflects temporary volatility or if the market is already accounting for its future growth potential and leaving limited upside.

Most Popular Narrative: 25.3% Undervalued

At a last close of $3.88 versus a most followed fair value of about $5.19, the current price sits well below the narrative’s implied level, putting the focus squarely on whether its growth playbook holds up.

The completed TransactPay acquisition gives Marqeta full program management and EMI capabilities in Europe, enabling entry into larger enterprise opportunities, uniformity of service across North America and Europe, and easier multi market expansion for clients. This unlocks new revenue streams, increases take rates, and improves earnings scalability.

Read the complete narrative.

The fair value story rests on a tight link between higher transaction volumes, richer take rates, and a future profit margin that looks very different to today. This raises the question of which growth levers and profit assumptions would need to align for the gap between $3.88 and $5.19 to close, and what kind of earnings profile the narrative is implicitly describing over the next few years.

Result: Fair Value of $5.19 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this depends on key risks not undermining the situation, particularly Marqeta’s reliance on major clients and the threat of tougher competition and regulation.

Find out about the key risks to this Marqeta narrative.

Another Lens on Value: Sales Multiple vs Peers

The fair value narrative leans on future earnings, but today’s pricing on current sales points in a different direction. At $3.88, Marqeta trades on a P/S of 2.5x, which is higher than the US Diversified Financial industry at 2.1x and well above peer averages around 1x.

The fair ratio implied by Simply Wall St data is 2.3x, so the current P/S sits above where the market could gravitate if expectations cool. For you, that raises a simple question: is this gap a sign of quality being priced in, or a margin of safety that has already been used up?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Uncertain about how all of this stacks up for you as an investor? Take a closer look at both sides of the story with 1 key reward and 2 important warning signs

Looking for more investment ideas?

If Marqeta no longer feels like the whole story, widen your opportunity set now. Some of the most interesting setups rarely stay overlooked for long.

• Target potential upside in smaller companies by reviewing 24 elite penny stocks with strong financials that already show stronger financial foundations.
• Prioritize price and quality together by scanning 48 high quality undervalued stocks that pair healthier balance sheets with supportive cash flows.
• Reduce portfolio stress by focusing on 63 resilient stocks with low risk scores that score well on resilience rather than short term excitement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com